In a previous study from this same cohort of patients, fetuin-A, inter-α-trypsin inhibitor 3, glutamic acid and cholesterol ester 18:0 were reported to be the most accurate biomarkers of the critical clinical progression of COVID-19 (9). The gene discussed is AHSG; the disease is COVID-19.